BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 30194558)

  • 1. Molecular pathways involved in microRNA-mediated regulation of multidrug resistance.
    Liao R; Lin Y; Zhu L
    Mol Biol Rep; 2018 Dec; 45(6):2913-2923. PubMed ID: 30194558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of potential miRNA therapeutics for the prevention of multi-drug resistance in cancer cells.
    Medarova Z; Pantazopoulos P; Yoo B
    Sci Rep; 2020 Feb; 10(1):1970. PubMed ID: 32029822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.
    Zhu W; Xu H; Zhu D; Zhi H; Wang T; Wang J; Jiang B; Shu Y; Liu P
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):723-31. PubMed ID: 21993663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Roles of microRNAs in Multidrug-Resistance Mechanisms in Gastric Cancer.
    Zeng X; Wang HY; Bai SY; Pu K; Wang YP; Zhou YN
    Curr Mol Med; 2020; 20(9):667-674. PubMed ID: 32209033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-mediated drug resistance in ovarian cancer.
    Mihanfar A; Fattahi A; Nejabati HR
    J Cell Physiol; 2019 Apr; 234(4):3180-3191. PubMed ID: 28628227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug resistance-related microRNAs in hematological malignancies: translating basic evidence into therapeutic strategies.
    Xie L; Jing R; Qi J; Lin Z; Ju S
    Blood Rev; 2015 Jan; 29(1):33-44. PubMed ID: 25263425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-129 regulates cisplatin-resistance in human gastric cancer cells by targeting P-gp.
    Lu C; Shan Z; Li C; Yang L
    Biomed Pharmacother; 2017 Feb; 86():450-456. PubMed ID: 28012924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches.
    Wu Q; Yang Z; Nie Y; Shi Y; Fan D
    Cancer Lett; 2014 Jun; 347(2):159-66. PubMed ID: 24657660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapy.
    To KK
    J Biomed Sci; 2013 Dec; 20(1):99. PubMed ID: 24358977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-223 modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells.
    Yang T; Zheng ZM; Li XN; Li ZF; Wang Y; Geng YF; Bai L; Zhang XB
    Exp Biol Med (Maywood); 2013 Sep; 238(9):1024-32. PubMed ID: 23925649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins.
    Genovese I; Ilari A; Assaraf YG; Fazi F; Colotti G
    Drug Resist Updat; 2017 May; 32():23-46. PubMed ID: 29145976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy and multidrug resistance in cancer.
    Li YJ; Lei YH; Yao N; Wang CR; Hu N; Ye WC; Zhang DM; Chen ZS
    Chin J Cancer; 2017 Jun; 36(1):52. PubMed ID: 28646911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-451 regulates chemoresistance in renal cell carcinoma by targeting ATF-2 gene.
    Sun X; Lou L; Zhong K; Wan L
    Exp Biol Med (Maywood); 2017 Jun; 242(12):1299-1305. PubMed ID: 28429654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
    Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
    Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The multi-factorial nature of clinical multidrug resistance in cancer.
    Assaraf YG; Brozovic A; Gonçalves AC; Jurkovicova D; Linē A; Machuqueiro M; Saponara S; Sarmento-Ribeiro AB; Xavier CPR; Vasconcelos MH
    Drug Resist Updat; 2019 Sep; 46():100645. PubMed ID: 31585396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance-related microRNAs in osteosarcoma: Translating basic evidence into therapeutic strategies.
    Chen R; Wang G; Zheng Y; Hua Y; Cai Z
    J Cell Mol Med; 2019 Apr; 23(4):2280-2292. PubMed ID: 30724027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA Therapeutics in Cancer - An Emerging Concept.
    Shah MY; Ferrajoli A; Sood AK; Lopez-Berestein G; Calin GA
    EBioMedicine; 2016 Oct; 12():34-42. PubMed ID: 27720213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA expression profiling in multidrug resistance of the 5‑Fu‑induced SGC‑7901 human gastric cancer cell line.
    Wang Y; Gu X; Li Z; Xiang J; Jiang J; Chen Z
    Mol Med Rep; 2013 May; 7(5):1506-10. PubMed ID: 23525256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-218 inhibits multidrug resistance (MDR) of gastric cancer cells by targeting Hedgehog/smoothened.
    Zhang XL; Shi HJ; Wang JP; Tang HS; Cui SZ
    Int J Clin Exp Pathol; 2015; 8(6):6397-406. PubMed ID: 26261515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA and drug resistance.
    Ma J; Dong C; Ji C
    Cancer Gene Ther; 2010 Aug; 17(8):523-31. PubMed ID: 20467450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.